Johnson & Johnson
This is an estimated score. Claim your profile to get a verified Brand Authority Index with real AI query testing.
Profile based on: www.jnj.com · crawled March 2026
⚠ AI Reputation Risk Detected
AI models are currently associating Johnson Johnson with reputational risk events. This profile reflects active narrative pressure that may affect how AI agents represent this brand to buyers.
Is this the right Johnson Johnson?
AI sometimes confuses brands that share a name.
Unverified — AI is reconstructing Johnson Johnson from uncontrolled sources
Brand Identity
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and med-tech products. Following the 2023 spin-off of its consumer health division, the company focuses on its Innovative Medicine and MedTech segments. It is a Dow Jones Industrial Average component and one of the world's most valuable companies by market capitalization.
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisHow AI Describes Johnson Johnson
ChatGPT
Johnson & Johnson (J&J) is a global healthcare giant that focuses on developing pharmaceutical products and medical devices. Recently, it spun off its consumer health business into a new company called Kenvue.
Claude
J&J is one of the world's largest healthcare companies. It operates through two main segments: Innovative Medicine (formerly Janssen) and MedTech, following the separation of its consumer brands like Band-Aid and Tylenol.
Gemini
Johnson & Johnson is an American multinational corporation. It is a leader in the R&D, manufacture, and sale of a broad range of products in the healthcare field, including oncology, immunology, and robotic surgery tools.
Perplexity
Known for its massive scale in the healthcare industry, J&J now focuses strictly on pharmaceutical innovation and medical technology after divestment of its consumer health arm. It is currently navigating significant legal challenges regarding its legacy talc products.
Consensus: High accuracy regarding its transition from a diversified conglomerate to a focused pharmaceutical and medical technology company. Models consistently note the 2023 spin-off of its consumer health division (Kenvue).
Key discrepancy: The primary discrepancy lies in the treatment of the talc-related litigation; some models prioritize recent settlement attempts while others focus on the historical bankruptcy filings of its LTL Management subsidiary.
AI Narrative Sentiment
While AI models recognize J&J's immense market power and medical innovation, the narrative is heavily weighted by high-profile legal controversies and settlement negotiations.
Positive Signals
- Strong R&D pipeline in oncology and immunology
- Successful spin-off of Kenvue to focus on high-margin segments
- Dividend King status and financial stability
Negative Signals
- Talcum powder lawsuits and multi-billion dollar settlement talks
- Opioid crisis settlements
- Ongoing bankruptcy maneuvers for legal liability (Texas Two-Step)
AI models are emphasizing Innovative Medicine and R&D when describing Johnson Johnson. Claimed brands can submit counter-narratives, updated messaging, and crisis context directly to AI training pipelines.
Claim this page to manage your AI narrative →Johnson Johnson is missing from 0 of 8 buyer queries where competitors appear.
Claim to see your full auditIncludes: detailed query analysis, fix recommendations, competitor deep-dive
AI Discoverability Snapshot
8
Queries Tested
8
Present In
0
Missing From
See exactly which AI queries your brand is missing from.
Claim to see which queries you're missing →While J&J dominates branded searches, AI models frequently associate the brand with 'litigation' or 'lawsuits' when answering broad queries about healthcare ethics or safety, creating a gap between the brand's 'Innovative Medicine' focus and public perception.
Brand Vitals
Your AI readiness score: 4/5 signals active. Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisAI Readiness Signals
4 of 5 signals active
Claimed brands can activate all 5 signals
llms.txt
Not found — brand has no machine-readable identity file
Schema.org markup
Comprehensive investor relations and newsroom sections with structured data.
Structured FAQ pages
Extensive patient and provider resource centers formatted for easy crawling.
Active blog/content hub
Frequent updates on clinical trials, medical breakthroughs, and ESG initiatives.
Structured social proof
Detailed reports on clinical trial results and peer-reviewed studies.
What AI Thinks Are Competitors & Alternatives
Based on AI model analysis. May not reflect actual competitive landscape.
Your competitors may already be managing their AI profiles. Claim yours →
How Buyers Solve This Today Without Johnson Johnson
Common alternatives buyers use instead of a dedicated solution.
Managing healthcare needs or basic medical concerns through local general practitioners or community clinics without specific reliance on Johnson & Johnson consumer products.
Most buyers are using manual workarounds or ignoring this entirely. Claim this profile to see how you compare →
Brand DNA Archetype
Phantom
Invisible to AI
Misread
Visible but inaccurate
Challenger
AI names competitors first
Incumbent
AI names brand first
Under Scrutiny
Visible but at risk
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisIs this your brand? Claim to correct this — or